LGI1 Antikörper (N-Term)

Produktnummer ABIN500152

Produktdetails anti-LGI1 Antikörper

Target: LGI1 (Leucine-Rich, Glioma Inactivated 1 (LGI1))

Bindungsspezifität: N-Term

Reaktivität: Maus, Human, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LGI1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA)

Spezifität: This antibody detects LGI1 at N-term. It is predicted to be specific to LGI1 and not recognize other LGI proteins.

Kreuzreaktivität (Details): Species reactivity (tested):Human, mouse, rat

Aufreinigung: Peptide affinity chromatography

Immunogen: LGI1 antibody was raised against a 13 amino acid peptide from near the amino terminus of human LGI1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA. Western blot: 1 - 2 μg/mL. Two isoforms of LGI1 are known to exist, but the top band seenin the western blot is likely to be non-specific.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS containing 0.02 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.

Details zu LGI1

Target: LGI1 (Leucine-Rich, Glioma Inactivated 1 (LGI1))

Andere Bezeichnung: LGI1 / EPT (LGI1 Produkte)

Synonyme: ADLTE antikoerper, ADPAEF antikoerper, ADPEAF antikoerper, EPITEMPIN antikoerper, EPT antikoerper, ETL1 antikoerper, IB1099 antikoerper, BB130740 antikoerper, MGC146600 antikoerper, LGIa antikoerper, fb78h12 antikoerper, wu:fb78h12 antikoerper, zgc:65886 antikoerper, leucine rich glioma inactivated 1 antikoerper, leucine-rich repeat LGI family, member 1 antikoerper, leucine-rich, glioma inactivated 1 antikoerper, leucine-rich, glioma inactivated 1b antikoerper, leucine-rich, glioma inactivated 1a antikoerper, LGI1 antikoerper, Lgi1 antikoerper, lgi1 antikoerper, lgi1b antikoerper, lgi1a antikoerper

Hintergrund: The leucine-rich, glioma inactivated gene 1 (LGI1) was first identified as a candidate tumor suppressor gene for glioma and may play a role in other cancers. LGI1 is a member of a family of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 serves as a ligand to ADAM22, a metalloprotease localized at the synapse. Mutations in LGI1 account for nearly half of autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Two isoforms of LGI1 are known to exist.Synonyms: Epitempin-1, Leucine-rich glioma-inactivated protein 1

Gen-ID: 9211

UniProt: O95970